INFLAMMATORY MARKERS IN CHILDREN WITH CONGENITAL HEART DEFECTS: A COMPARATIVE ANALYSIS BY LEVEL OF IMMUNE ACTIVATION

Authors:

Abstract:

The purpose of the study was to assess the immune status and levels of inflammatory markers in children with congenital heart defects, taking into account the degree of immune activation. A comparative analysis was conducted between patients with high and low immune activation, as well as a control group of healthy children. The study included 80 patients with congenital heart defects and 20 healthy children. The investigated parameters included CD3, CD4, CD8, CD95, CD16/56, CD19, HLA-DR, interleukin-6, tumor necrosis factor-alpha, as well as indicators of cardiac remodeling. The obtained results make it possible to identify immune phenotypes associated with disease progression and may be used for patient stratification and the development of personalized therapeutic approaches.

Keywords:

congenital heart defects immune status inflammation apoptosis CD3 CD4 CD95 interleukin-6 TNF-α

References:

1. Ahmed R, Zaman M, Rafiq S, Noor A, Khatoon A. The role of HLA-DR and CD95 in pediatric congenital heart disease. Pediatr Immunol. 2021;30(4):179–185. https://doi.org/10.1016/j.pedimm.2021.03.004.
2. Chen L, Zhang W, Zhang J, Liu M, Wu X, Chen Z. Cytokine profiles in children with congenital heart disease: a prospective study. Front Pediatr. 2022;10:879115. https://doi.org/10.3389/fped.2022.879115.
3. Freeman JV, Baer RJ, Sathe NA, Carmichael SL, Croen LA, Jelliffe-Pawlowski LL. Population health perspectives on immune function in children with congenital anomalies. BMC Pediatr. 2023;23:119. https://doi.org/10.1186/s12887-023-03954-2.
4. García-Guereta L, Monleón JG, Torres L, López-González JL, Romero A. Immunophenotyping in children with congenital heart disease. Pediatr Allergy Immunol. 2021;32(2):324–331. https://doi.org/10.1111/pai.13418.
5. Kumar R, Singh R, Sharma M, Gupta V, Mehra A, Joshi N. Immune dysfunction in congenital heart disease: a pediatric insight. Pediatr Cardiol. 2021;42(3):489–497. https://doi.org/10.1007/s00246-020-02446-z.
6. Lee JH, Kim YS, Park SH, Cho JW, Han SY, Kang HJ. Inflammatory markers and cardiac remodeling in children with cyanotic congenital heart defects. Int J Cardiol. 2023;368:45–52. https://doi.org/10.1016/j.ijcard.2022.12.005.
7. Liu J, Zhao X, Yu Y, Xu T, Zhang J. Flow cytometry evaluation in pediatric cardiology: immune cell patterns. Cytometry B Clin Cytom. 2022;102(3):215–222. https://doi.org/10.1002/cyto.b.21981.
8. Novak J, Svoboda T, Hlavata K, Doležalová H, Pešek M. Immunological profiles in children with ventricular septal defects. Clin Exp Immunol. 2021;204(2):233–240. https://doi.org/10.1111/cei.13575.
9. Oliveira M, Silva V, Ferreira C, Mendes L, Costa J, Santos R. Diagnostic and prognostic value of immune markers in children with congenital heart disease. Curr Pediatr Rev. 2020;16(2):110–117. https://doi.org/10.2174/1573396315666191227094715.
10. Özkan S, Ekinci S, Yıldız M, Kaya A, Uçar T. Apoptosis and immunity in pediatric congenital cardiac surgery. J Pediatr Surg. 2021;56(10):1870–1876. https://doi.org/10.1016/j.jpedsurg.2021.01.033.
11. Patel N, Desai S, Vyas H, Kaur R, Shah M. Pediatric inflammatory responses in cyanotic heart defects. J Pediatr Surg. 2022;57(6):1015–1020. https://doi.org/10.1016/j.jpedsurg.2021.10.021.
12. Sato K, Inoue M, Ogawa T, Nakamura Y, Honda R. TNF-α and IL-6 levels in pediatric cardiac patients. Cytokine. 2020;125:154823. https://doi.org/10.1016/j.cyto.2019.154823.
13. Singh K, Malhotra R, Verma A, Jain P, Tiwari S, Goel N. Role of apoptosis in the progression of congenital heart defects. J Immunol Res. 2020;2020:5856231. https://doi.org/10.1155/2020/5856231.
14. Wang Y, Yang L, Wang Y, Zhang F, Chen Y. Cardiac remodeling and immune response in congenital heart disease. Heart Fail Rev. 2023;28(1):45–59. https://doi.org/10.1007/s10741-021-10139-3.
15. Zhao H, Zhang Y, Li L, Sun J, Wang C, Li Q. Programmed cell death in children with congenital heart anomalies. Mol Cell Biochem. 2020;469(1–2):1–9. https://doi.org/10.1007/s11010-019-03540-w.

Publication:

«World of Medicine and Biology» Vol. 21 No. 92 (2025) , с. 95-98
УДК 616.12-007.1-053.1-053.2]-07:612.017.1

DOI:

https://doi.org/10.26724/2079-8334-2025-2-92-95-98